Clinical trial
A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
NCT07357740
Study timeline
Study start (estimated)2026-08-27Date precision: day
Registry last updated2026-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
CagriSemaDRUG
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
BarcelonaSpain3ThessalonikiGreece3MiamiFlorida, United States2BangkokThailand2BelgradeSerbia2Pembroke PinesFlorida, United States2HoustonTexas, United States1San AntonioTexas, United States1NashvilleTennessee, United States1San DiegoCalifornia, United States1SevilleSpain1Little RockArkansas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07357740 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.